Generic Name and Formulations:
Fluorescein (as sodium) 100mg/mL (10%); soln for IV inj; preservative-free.
Alcon Laboratories, Inc.
Indications for FLUORESCITE:
Diagnostic angiography or angioscopy of the retina and iris vasculature.
Give by IV inj rapidly into the antecubital vein (normally 1mL/sec). 500mg (5mL). Highly sensitive imaging system (eg, scanning laser ophthalmoscope): reduce dose to 2mL.
Give by IV inj rapidly into the antecubital vein (normally 1mL/sec). 7.7mg/kg; max 500mg (5mL).
History of allergy. Bronchial asthma. Avoid extravasation; severe local tissue damage can result. Pregnancy. Nursing mothers: discontinue for ≥4 days after inj (pump and discard the milk during this period).
Skin and urine discoloration, nausea, vomiting, GI distress, hypersensitivity reactions, headache, thrombophlebitis; rare: cardiopulmonary reactions, convulsions, syncope.
Single use vial (5mL)—1
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Cognitive Behavioral Therapy May Alter Suicidal Ideation in Anxiety Disorders
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Cost-Effective Telehealth Alternatives for Veterans With Depression
- Polygenic Risk Scores Could Aid in Identifying Bipolar Disorder, Schizophrenia
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses